Antibiotic therapy has been of unquestionable value in terms of saving lives and reducing suffering caused by infectious diseases. However, the widespread and indiscriminant use of antibiotics has not been without significant consequences. Some of these consequences include increased antibiotic resistance in pathogenic strains of bacteria. In addition, the indiscriminate use of antibiotics has recently been shown to alter the host microbiota and this has been associated with chronic disease. However, abandoning the use of antibiotics would be unthinkable. We have been exploring a strategy of modulating the host tolerance/resistance mechanisms as a means to ablate infection. We postulate that the obvious advantage of this therapeutic strategy is that, by targeting host tolerance/resistance mechanisms, the selective pressure for the expression of pathogen resistance is greatly reduced or altogether absent.
Taubes, G. (2008) The bacteria fight back. Science, 321, 356-361. doi:10.1126/science.321.5887.356
Klevens, R.M., Morrison, M.A., Nadle, J., Petit, S., Gershman, K., Ray, S., et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA, 298, 1763-1771. doi:10.1001/jama.298.15.1763
Bancroft, E.A. (2007) Antimicrobial resistance: It’s not just for hospitals. JAMA, 298, 1803-1804. doi:10.1001/jama.298.15.1803
D’Agata, E.M., Webb, G.F., Horn, M.A., Moellering, R.C. and Ruan, S. (2009) Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clinical Infectious Diseases, 48, 274-284. doi:10.1086/595844
Farley, J.E. (2008) Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. Journal of the American Academy of Nurse Practitioners, 20, 85-92. doi:10.1111/j.1745-7599.2007.00290.x
Wright, G.D. (2010) Antibiotic resistance: Where does it come from and what can we do about it? BMC Biology, 8, 123. doi:10.1186/1741-7007-8-123
D’Costa V.M., King, C.E., Kalan, L., Morar, M., Sung, W.W., Schwarz, C., et al. (2011) Antibiotic resistance is ancient. Nature, 477, 457-461. doi:10.1038/nature10388
Bennett, P.M. (2008) Plasmid encoded antibiotic resistance: Acquisition and transfer of antibiotic resistance genes in bacteria. British Journal of Pharmacology, 153, S347-S357. doi:10.1038/sj.bjp.0707607
Ohnishi, M., Golparian, D., Shimuta, K., Saika, T., Hoshina, S., Iwasaku, K., et al. (2011) Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrobial Agents and Chemotherapy, 55, 3538-3545. doi:10.1128/AAC.00325-11
Dethlefsen, L., Fall-Ngai, M. and Relman, D.A. (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature, 449, 811-818. doi:10.1038/nature06245
Blaser, M.J. and Kirschner, D. (2007) The equilibria that allow bacterial persistence in human hosts. Nature, 449, 843-849. doi:10.1038/nature06198
Blaser, M.J. and Falkow, S. (2009) What are the consequences of the disappearing human microbiota? Nature Reviews Microbiology, 7, 887-894. doi:10.1038/nrmicro2245
Curtis, M.M. and Way, S.S. (2009) Interleukin-17 in host defense against bacterial, mycobacterial and fungal pathogens. Immunology, 126, 177-185. doi:10.1111/j.1365-2567.2008.03017.x
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., et al. (2007) Phenotypic and functional features of human Th17 cells. The Journal of Experimental Medicine, 204, 1849-1861. doi:10.1084/jem.20070663
Blaser, M.J., Chen, Y. and Reibman, J. (2008) Does Helicobacter pylori protect against asthma and allergy? Gut, 57, 561-567. doi:10.1136/gut.2007.133462
Koenen, H.J., Smeets, R.L., Vink, P.M., van Rijssen, E., Boots, A.M. and Joosten, I. (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood, 112, 2340-2352. doi:10.1182/blood-2008-01-133967
Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Liggett, C.M., Knight, R. and Gordon, J.I. (2007) The human microbiome project. Nature, 449, 804-810. doi:10.1038/nature06244
Jukes, T. (2012) Antibiotics in animal feeds and production. Bioscience, 22, 526-534. doi:10.2307/1296312
Albrich, W.C., Baughman, W., Schmotzer, B. and Farley, M.M. (2007) Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clinical Infectious Diseases, 44, 1569-1576. doi:10.1086/518149
Regev-Yochay, G., Dagan, R., Raz, M., Carmeli, Y., Shainberg, B., Derazne, E., et al. (2004) Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA, 292, 716-720. doi:10.1001/jama.292.6.716
Regev-Yochay, G., Bogaert, D., Malley, R., Hermans, P.W., Veenhoven, R.H., Sanders, E.A., et al. (2008) Does pneumococcal conjugate vaccine influence Staphylococcus aureus carriage in children? Clinical Infectious Diseases, 47, 289-291. doi:10.1086/589573
Rasko, D.A., Moreira, C.G., Li, D.R., Reading, N.C., Ritchie, J.M., Waldor, M.K., et al. (2008) Targeting QseC signaling and virulence for antibiotic development. Science, 321, 1078-1080. doi:10.1126/science.1160354
Schneider, D.S. and Ayres, J.S. (2008) Two ways to survive infection: What resistance and tolerance can teach us about treating infectious diseases. Nature Reviews Immunology, 8, 889-895. doi:10.1038/nri2432
Chu, J., Thomas, L.M., Watkins, S.C., Franchi, L., Nunez, G. and Salter, R.D. (2009) Cholesterol-dependent cytolysins induce rapid release of mature IL-1beta from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner. Journal of Leukocyte Biology, 86, 1227-1238. doi:10.1189/jlb.0309164
Dostert, C., Guarda, G., Romero, J.F., Menu, P., Gross, O., Tardivel, A., et al. (2009) Malarial hemozoin is a Nalp3 inflammasome activating danger signal. The Public Library of Science One, 9, e6510.
Gurcel, L., Abrami, L., Girardin, S., Tschopp, J., van der Goot, F.G. (2006) Caspase-1 activation of lipid metabolic pathways in response to bacterial poreforming toxins promotes cell survival. Cell, 126, 1135-1145. doi:10.1016/j.cell.2006.07.033
Thomas, P.G., Dash, P., Aldridge, J.R., Ellebedy, A.H., Reynolds, C., Funk, A.J., et al. (2009) The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity, 30, 566-575. doi:10.1016/j.immuni.2009.02.006
Cassel, S.L., Eisenbarth, S.C., Lyer, S.S., Sadler, J.J., Colegio, O.R., Tephly, L.A., et al. (2008) The NALP3 inflammasome is essential for the development of silicosis. Proceeding of the National Academy Sciences of the USA,105, 9035-9040. doi:10.1073/pnas.0803933105
Dostert, C., Petrilli, V., van Bruggen, R., Steele, C., Mossman, B.T. and Tschopp, J. (2008) Innate immune activation through NALP3 inflammasome sensing of asbestos and silica. Science, 320, 674-677. doi:10.1126/science.1156995
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E.O., Kono, H., Rock, K.L., et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nature Immunology, 9, 847- 856. doi:10.1038/ni.1631
Gasse, P., Riteau, N., Charron, S., Girre, S., Fick, L., Petrilli, V., et al. (2009) Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. American Journal of Respiratory and Critical Care Medicine, 179, 903-913. doi:10.1164/rccm.200808-1274OC
Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O’Rourke, K., Roose-Girma, M., et al. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature, 440, 228-232. doi:10.1038/nature04515
Salminen, A., Ojala, J., Suuronen, T., Kaarniranta, K. and Kauppinen, A. (2008) Amyloid-β oligomers set fire to inflammasomes and induce Alzheimer’s pathology. Journal of Cellular and Molecular Medicine, 12, 2255-2262. doi:10.1111/j.1582-4934.2008.00496.x
Yamasaki, K., Muto, J., Taylor, K.R., Cogen, A.L., Audish, D., Bertin, J., et al. (2009) NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. The Journal of Biological Chemistry, 284, 12762-12771. doi:10.1074/jbc.M806084200
Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., Booth, C.J., et al. (2011) NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell, 145, 745-757. doi:10.1016/j.cell.2011.04.022
Thacker, J.D., Sassi-Gaha, S., Stephens, C., Purohit, M., Rest, R.F. and Artlett, C.M. (2012) NLRP3 Inflammasome is a target for development of broad-spectrum anti-infective drugs. Antimicrobial Agents Chemotherapy, 56, 1921-1930. doi:10.1128/AAC.06372-11
Henan-Mejia, I., Elinav, E., Strowig, T. and Flavell, R.A. (2012) Inflammasomes: Far beyond inflammation. Nature Immunology, 13, 321-324. doi:10.1038/ni.2257
Franchi, L., Mu?oz-Planillo, R. and Nú?ez, G. (2012) Sensing and reacting to microbes through inflammasomes. Nature Immunology, 13, 325-332. doi:10.1038/ni.2231
Zitvogel, L., Kepp, O., Galluzzi, L. and Kroemer, G. (2012) Inflammasomes in carcinogenesis and anticancer immune responses. Nature Immunology, 13, 343-351. doi:10.1038/ni.2224